Omega-3 Polyunsaturated Fatty Acids in Children with Attention Deficit Hyperactivity Disorder: A Systematic Review

Main Article Content

Ana Beatriz Ferreira Rolim
Anna Carolyna Gianlorenco
Arthur Andrade Braga
Belen Rivera
Bruno Francisco Buzetti Spinelli
Camila María Martínez Marte
Danilo Hantschick Fernandes Monteiro
Elisa Rodriguez
Eneidy Pina
Eva Dias Costa
Ewerton Alves Portela dos Santos
Gabriel Sant'Ana Carrijo
Gabriella Moreira Requião
Gilberto Perez Rodriguez Garcia
Iyanuoluwa O. Ojo
Kasiemobi Eberechukwu Uchime
Luciana Valentina Olivera González
Luiz Fernando Mantovani
Maraisa do Nascimento
María Alejandra Rodríguez Brilla
Marília Aparecida Silva Oliveira Machado
Mutwakil Elbidiari
Natasha Carvalho Pandolfi
Nicole Nakousi-Capurro
Qudus Olajide Lawal
Tamara Zompa
Tatiane Aparecida de Miranda
Tomás Ignacio Rybertt Lorca
Tomás Pablos Aros

Abstract

INTRODUCTION. Attention Deficit-Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder that affects a significant population of children. Omega-3 supplementation is being explored as an option since standard pharmacological treatments cause bothersome side effects. Systematic reviews and meta-analyses on its effects are outdated and show gaps in knowledge. Our objective is to examine the impact of Omega-3 fatty acids on the symptoms of ADHD in children.


METHODS. RCTs were searched in MEDLINE, Embase, and Web of Science until May 1st 2024. Studies were included if they involved children aged 6-18 with ADHD who consumed Omega-3 fatty acids through diet or supplementation. Studies were excluded if they included individuals without an ADHD diagnosis, used animal models, or included vitamin supplements alongside Omega-3. Data extraction and Cochrane Risk-of-Bias analysis was performed using Covidence. Findings were described in tables and analyzed. 


RESULTS. Thirty-one eligible RCTs were included, amounting to 2,739 evaluated individuals with an average age of 8.93 years (SD = 1.39). Most studies had a two-arms design that compared Omega-3 vs. placebo. The effect on hyperactivity and impulsivity was reported in 23 studies, of which fourteen showed no effect and seven reported positive results. Ten out of 24 studies (41.6%) that evaluated inattention reported improvements. 


DISCUSSION. Studies were highly heterogeneous in design, interventions, trial duration, dosage, and outcome measurement tools. Overall, Omega-3 may not have a significant effect on ADHD symptoms to recommend its use. Future research should address the principal limitations on study designs.

Article Details

How to Cite
Omega-3 Polyunsaturated Fatty Acids in Children with Attention Deficit Hyperactivity Disorder: A Systematic Review. (2025). Principles and Practice of Clinical Research, 10(4). https://doi.org/10.21801/ppcrj.2024.104.4
Section
Full Length Articles

How to Cite

Omega-3 Polyunsaturated Fatty Acids in Children with Attention Deficit Hyperactivity Disorder: A Systematic Review. (2025). Principles and Practice of Clinical Research, 10(4). https://doi.org/10.21801/ppcrj.2024.104.4

Most read articles by the same author(s)